Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
17,659,276
-
Share change
-
-547,807
-
Total reported value
-
$118,497,474
-
Put/Call ratio
-
58%
-
Price per share
-
$6.71
-
Number of holders
-
62
-
Value change
-
-$4,034,573
-
Number of buys
-
34
-
Number of sells
-
25
Institutional Holders of AC Immune SA - SHS (ACIU) as of Q3 2021
As of 30 Sep 2021,
AC Immune SA - SHS (ACIU) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,659,276 shares.
The largest 10 holders included
BVF INC/IL, Avidity Partners Management LP, PLATINUM INVESTMENT MANAGEMENT LTD, Artal Group S.A., SUVRETTA CAPITAL MANAGEMENT, LLC, EcoR1 Capital, LLC, Balyasny Asset Management LLC, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
62
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.